Serum Hepatocyte Growth Factor Levels Predict Long-Term Clinical Outcome after Percutaneous Coronary Revascularization.
European heart journal(2005)SCI 1区
INSERM-ESPRI Department of Hematology | INSERM-ESPRI Department of Cardiology | University Hospital Department of Biochemistry | Institut Pasteur INSERM-U508 | University Hospital Department of Cardiology | Hop Cardiol
- Pretraining has recently greatly promoted the development of natural language processing (NLP)
- We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
- We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
- The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
- Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance

Therapeutic Effect of Hepatocyte Growth Factor on Coronary Heart Disease
被引用3
被引用8
被引用16
被引用0
HEPATOCYTE GROWTH FACTOR AND VISFATIN IN ELDERLY BEDRIDDEN PATIENTS
被引用1
CD34+ Cells Augment Endothelial Cell Differentiation of CD14+ Endothelial Progenitor Cells in Vitro
被引用48
被引用195
Adipose Tissue Production of Hepatocyte Growth Factor Contributes to Elevated Serum HGF in Obesity.
被引用103
被引用123
被引用21
被引用16
被引用33
Hepatocyte Growth Factor and Interferon‐γ Inducible Protein‐10 Are Related to Visceral Adiposity
被引用14
Hepatocyte Growth Factor is Elevated in Obese Adolescents
被引用32
被引用13
被引用16
被引用28
被引用28
Hepatocyte Growth Factor Demonstrates Racial Heterogeneity As a Biomarker for Coronary Heart Disease
被引用24
被引用4
被引用76
被引用17
被引用2